1. Home
  2. CLPT vs ASMB Comparison

CLPT vs ASMB Comparison

Compare CLPT & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$14.01

Market Cap

494.6M

Sector

Health Care

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$33.29

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPT
ASMB
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.6M
553.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
CLPT
ASMB
Price
$14.01
$33.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$27.67
$43.40
AVG Volume (30 Days)
699.8K
140.2K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,332,000.00
$37,191,000.00
Revenue This Year
$18.93
$33.33
Revenue Next Year
$51.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.83
31.30
52 Week Low
$9.76
$7.75
52 Week High
$30.10
$39.71

Technical Indicators

Market Signals
Indicator
CLPT
ASMB
Relative Strength Index (RSI) 45.66 46.76
Support Level $14.01 $31.51
Resistance Level $14.61 $38.99
Average True Range (ATR) 0.79 2.15
MACD 0.36 -0.32
Stochastic Oscillator 59.41 25.13

Price Performance

Historical Comparison
CLPT
ASMB

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: